or Try an Advanced Search...

    Advanced Prostate Cancer Stocks List

    Symbol Grade Name % Change
    ABBV D AbbVie Inc. 1.85
    EPIX D ESSA Pharma Inc. -1.01
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Pharmaceutical Adalimumab Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cancer Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Histopathology Hypothyroidism

    Related ETFs - A few ETFs which own one or more of the above listed Advanced Prostate Cancer stocks.

    Symbol Grade Name Weight
    MEDI C Harbor Health Care ETF 9.87
    HDLB C ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 8.97
    GRID A First Trust NASDAQ Clean Edge Smart Grid Infrastructure Index Fund 8.3
    MEDX F Horizon Kinetics Medical ETF 7.88
    View all Advanced Prostate Cancer ETFs...
    Compare ETFs
    Compare GRID to MEDX Compare HDLB to BOTZ Compare HDLB to GRID

        Advanced Prostate Cancer Stocks Recent News

        Date Stock Title
        May 3 ABBV Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
        May 3 ABBV Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
        May 2 ABBV Top 25 Stocks in the S&P 500 by Index Weight Right Now
        May 2 ABBV The top pharmaceutical companies by R&D expenditure
        May 1 ABBV BeiGene, AbbVie patent spat to get trial from USPTO appeals board
        May 1 ABBV CVS stock plunges after earnings numbers one analyst 'did not even believe'
        Apr 30 ABBV Trials to watch: Four ALS drugs to keep an eye on
        Apr 30 ABBV AbbVie (ABBV) Could Be a Great Choice
        Apr 30 ABBV AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
        Apr 30 ABBV Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
        Apr 29 ABBV AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
        Apr 29 ABBV AbbVie: The Inevitable Is Happening
        Apr 29 ABBV Unveiling AbbVie's Winning Strategy In Pharmaceutical Innovation (Rating Upgrade)
        Apr 29 ABBV Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
        Apr 28 ABBV Dividend Stock Portfolio For Income: Top 15 Stocks
        Apr 28 ABBV AbbVie First Quarter 2024 Earnings: Beats Expectations
        Apr 28 ABBV Better Dividend Stock: AbbVie or Johnson & Johnson?
        Apr 27 ABBV 3 Dividend Stocks to Buy and Hold for the Next Decade
        Apr 27 ABBV AbbVie Inc (ABBV) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...
        Apr 27 ABBV Q1 2024 AbbVie Inc Earnings Call
        Related Industries: Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Pharmaceutical Adalimumab Anemia Atopic Dermatitis Autoimmune Disease Blood Cancers Cancer Chronic Idiopathic Constipation Combination Drugs Constipation Crohn's Disease Depressive Disorder Endometriosis Eye Care Products Genotype Hematological Malignancies Hepatitis C Hepatitis C Virus Histopathology Hypothyroidism
        Advanced Prostate Cancer

        Advanced prostate cancer is a form of prostate cancer that has spread beyond the prostate gland to other parts of the body, such as the bones, lymph nodes, or other organs. It is also known as metastatic prostate cancer. Advanced prostate cancer is typically more difficult to treat than early-stage prostate cancer, and the prognosis is generally poorer. Treatment options may include hormone therapy, chemotherapy, radiation therapy, and/or surgery.

        Browse All Tags